CYCLO THERAPEUTICS INC (CYTH) Stock Analyst Ratings
NASDAQ:CYTH - Nasdaq - US23254X2018 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to CYTH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.97. This target is 34.47% above the current price.
CYTH was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CYTH.
In the previous month the buy percentage consensus was at a similar level.
CYTH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-27 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-08-26 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-01 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-22 | Ascendiant Capital | Initiate | Buy |
| 2023-09-27 | Maxim Group | Upgrade | Hold -> Buy |
| 2023-03-21 | Maxim Group | Downgrade | Buy -> Hold |